Attitudes of older adults with serious competing health risks toward their implantable cardioverter-defibrillators: a pilot study by unknown
RESEARCH ARTICLE Open Access
Attitudes of older adults with serious
competing health risks toward their
implantable cardioverter-defibrillators:
a pilot study
Ariel R. Green1*, Cynthia M. Boyd1, John Rickard2, Robert Gomon2 and Bruce Leff1,3,4
Abstract
Background: In elderly heart failure patients, the survival benefit of implantable cardioverter-defibrillators (ICDs)
may be attenuated due to competing health risks, and the risk of adverse outcomes magnified. Our objective was
to examine older adults’ attitudes towards ICD implantation in the context of competing health risks, exploring the
determinants of ICD decision-making among a group of patients who had faced the decision in the past.
Methods: Telephone survey with a qualitative component. Patients were age ≥70 with single- or dual-chamber
ICDs from a single academic cardiac device clinic. Health status was assessed with the Vulnerable Elders Survey
(VES-13). Responses to open-ended questions were transcribed verbatim; an “editing analysis” approach was used
to extract themes.
Results: Forty-four ICD recipients participated (mean age 77.5 years). Nineteen participants (43 %) had VES-13
scores ≥3, indicating a 50 % likelihood of death or functional decline within 2 years. Twenty-one participants (48 %)
had received prior ICD shocks. Forty participants (91 %) said they would “definitely” choose to get an ICD again in
their current health. By and large, patients revealed a strong desire to extend life, expressed complete confidence in
the lifesaving capabilities of their ICDs, and did not describe consideration of competing health risks.
Conclusions: In this pilot telephone survey with a qualitative component, nearly all older adults with ICDs would
still choose to get an ICD despite high short-term risk of death or health deterioration. These findings suggest the
need to partner more effectively with patients and families to decide how best to use medical technologies,
particularly for older adults with competing risks.
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Background
Despite a lack of conclusive evidence of effectiveness for
older adults, over 40 % of the 110,000 implantable
cardioverter-defibrillators (ICDs) implanted in the U.S.
each year are in patients over age 70, and 10 to 20 % are
in patients over age 80 [1–3]. Primary prevention ICD
clinical trials demonstrated no survival advantage for the
first 9–18 months after implantation [4, 5]. The 1-year
mortality rate for a 75-year-old patient hospitalized with
heart failure and low ejection fraction is 30–50 %, and
fewer than 10 % of deaths in this population are due to
sudden cardiac death [6]. Thus, many of these deaths
are due to competing health risks.
ICDs are a prophylactic therapy that carry risks: post-
procedural complications, an increase in hospitaliza-
tions, inappropriate shocks, and futile end-of-life
shocks among patients dying of non-arrhythmic causes
[7–9]. Furthermore, ICDs (in the absence of cardiac
resynchronization therapy, or CRT) do not affect heart
failure symptoms, and their effect on quality of life is,
at best, neutral. However, data suggest that patients
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may consent to implantation with the expectation that
their physical health and functioning will improve [10].
This misconception is particularly important for older
adults with multiple coexisting illnesses, in whom ICDs
are unlikely to result in a survival benefit, and may
make life and death more onerous [11–13].
We hypothesized that older adults considering ICD
therapy do not weigh their competing risks for mortality,
and that this unrealistic approach leads to ICD implant-
ation in situations where there may be harms without
benefit. Our objective was to examine older adults’
attitudes towards ICD implantation in the context of
competing health risks, exploring the determinants of
ICD decision-making among a group of patients who
had faced the decision in the past.
Methods
Study design, setting and participants
This was a cross-sectional telephone survey and qualita-
tive study of older adults (≥70 years) with ICDs placed
for either primary or secondary preventive purposes,
who were actively being followed in the cardiac device
clinic of Johns Hopkins Bayview Medical Center, an aca-
demic medical center. Patients were identified from the
clinic database.
Eligible participants were English-speaking and had
a single or dual-lead ICD (not capable of CRT). We
excluded patients who had dementia or lived in a
nursing home, based on a family member’s report
(Fig. 1), because they may lack capacity to make
medical decisions. We also excluded patients whose
ICDs had been deactivated, because we wanted to
probe determinants of ICD decision-making among
patients who were likely to face the decision again
in the future.
One investigator (RG) identified potential participants
and sought their approval to be contacted about the study
by telephone. Those who agreed were contacted by the
principal investigator (AG), a geriatrician with experience
conducting research interviews. She explained the purpose
and procedures of the study in detail, obtained verbal
informed consent, and administered a 15-min telephone
survey with a qualitative component. After giving in-
formed consent, participants completed the survey during
the same phone call. Surveys were completed between
April and November 2013. The study was approved by the
Johns Hopkins University School of Medicine Institutional
Review Board.
Survey development and administration
The pilot study consisted of a 29-question survey on
demographics, medical history, functional status, percep-
tions of ICD benefit and burdens, personal experiences
with the ICD, and health literacy. The medical history
questions included geriatric impairments such as urinary
or fecal incontinence, difficulty walking, frequent falls,
dizziness, depression or sadness, and problems with
hearing or vision.
To identify participants at increased risk of death or
functional decline within 2 years, we used the Vulnerable
Elders Survey (VES-13) [14]. The VES-13 is a 13-question
screen that uses self-reported health and functional status
measures to predict health deterioration. The survey
was developed among 6205 nationally representative,
community-dwelling Medicare beneficiaries ≥65 years,
and has been validated in other populations of older
adults [15–18]. Fifty percent of older adults with a
score of ≥3 experience functional decline (defined as
change from no functional disability to any functional
disability, an increase of two or more in the total
Fig. 1 Patients were identified from the clinic database. Eligible participants were English-speaking and had a single or dual-lead ICD (not capable
of CRT)
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disability count, or admission to a nursing home) or die in
a 2-year period and have 4.2 times the risk of death or
decline, compared with those with scores <3 [14].
Perceptions of ICD benefit and burdens were assessed
by asking participants, “In your current health state, do
you feel that the potential benefit of your ICD is worth
the burdens?” and “In your current health state, if you
had the decision to make over again, would you still
choose to get an ICD?” The latter question was adapted
from the Decision Regret Scale, a questionnaire for
measuring regret after health care decisions [19]. Partici-
pants responded using a Likert scale ranging from 1
(“definitely no”) to 5 (“definitely yes”) and were then
asked to provide an open-ended explanation. The survey
also included two additional open-ended questions:
“What do you feel are the potential benefits of your
ICD?” and “What do you feel are the potential harms of
your ICD?” [20].
Participants were asked if they had experienced any
device activity or complications, and if they thought
their ICD had saved their life (“yes,” “no,” or “not sure”).
We also assessed their understanding of ICD survival
benefit and function, including device deactivation, using
multiple-choice questions adapted from prior studies
[21]. Because limited health literacy may be associated
with worse health outcomes, poorer knowledge about
health conditions and poorer self-reported health, we
assessed health literacy with a 3-item screening tool
with established validity [22]. Using established methods,
we assigned 0 (no problems with reading) to 4 points
(highest problems with reading) to the responses for each
question. Scores for the 3 questions were combined to ob-
tain a 12-point scale, with 0 = no problems with health lit-
eracy and 12 = highest problems with health literacy [22].
Outcome
The main outcome was the proportion of participants
who would still get an ICD in their current health state,
if they had the choice to make again.
Analysis
We used descriptive statistics to explore baseline char-
acteristics of the population. The VES-13 was scored
using a range of 1–10 with higher scores indicating
greater likelihood of death or functional decline. Stata/
SE version 12 was used for analyses (StataCorp. 2013.
Stata Statistical Software: Release 13. College Station,
TX: StataCorp LP).
Interviews were not recorded. Responses to the open-
ended questions were transcribed verbatim and used for
a qualitative analysis regarding older adults’ personal
thoughts and experiences surrounding ICD decision
making in the context of competing health risks. Tran-
scripts were not returned to participants for comment
and/or correction. Qualitative analysis was performed by
extracting themes from the transcripts guided by our
research questions. An “editing analysis” approach was
used to extract themes until saturation was reached. In
this method, a coding template is derived from the data
itself. [23] Two investigators (AG and BL) independently
reviewed all transcripts to extract preliminary categories
of themes. The transcripts were reviewed iteratively to
make modifications to the coding template and add new
categories as needed. The study group then reviewed the
findings and organized the categories into themes for
presentation. Differences were discussed and resolved by
consensus. Quotations that the investigators deemed to
be most representative of the responses were selected
for inclusion. Participants were not asked to provide
feedback on the findings. Consistent with best practices
on rigorously evaluating mixed methods research in the
health sciences [24], we report the quantitative data in
conjunction with qualitative quotes and themes that




The clinic database included 328 patients with ICDs.
After excluding patients who were <70 years of age
(n = 204), had dementia (n = 10), or whose devices had
been inactivated (n = 2) or upgraded to CRT-D (n = 4),
108 eligible patients remained. Of those, 33 were lost
to clinic follow-up, 12 did not respond to repeated
phone calls, and 4 had died (Fig. 1). Fifty-nine eligible
patients were contacted by RG; 44 agreed to partici-
pate (75 % response rate).
Table 1 depicts the demographic characteristics,
baseline health, and VES scores of the participants. In
general, participants were elderly, male, and white,
with a high prevalence of comorbidities and geriatric
impairments. The mean (SD) health literacy score was
2.3 (2.4) out of 12. The mean (SD) VES-13 score was
3 (2.8). Nineteen respondents (43 %) had VES-13
scores ≥3. The average (SD) length of time from
initial ICD placement to the start of the study was
7.3 (3.9) years.
Preferences for ICD therapy
Our primary objective was to determine whether older
adults would choose to get an ICD again in their
current health. Overall, 91 % of participants (40 of 44)
said they would “definitely” choose to get an ICD
again in their current health and 7 % (3 of 44) said
they would “possibly” choose to get one again. Simi-
larly, 98 % of participants felt that in their current
health, the potential benefits of their ICD were worth
the burdens.
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Qualitative findings
By and large, patients revealed a strong desire to extend
life, expressed complete confidence in the lifesaving
capabilities of their ICDs, and did not describe consider-
ation of competing health risks. Two major themes
emerged as patients discussed their attitudes towards
ICD implantation in the context of competing health
risks: (1) Decision making, and (2) Perceived benefits
and burdens. Within the decision making theme, there
were several sub-themes: (a) Societal bias toward life
extension/Personal desire to avoid death; (b) ICD as an
“insurance policy” worth having; (c) Lack of participation
in decision making/Reliance on doctor to make the
decision; and (d) Consideration of competing health
risks. Within the perceived benefits and burdens theme,
there were two sub-themes: (a) Poor understanding of
ICD risks and benefits/Belief that ICD will improve
quality of life; and (b) Burdens of living with an ICD.
Representative quotes from participants are below and
depicted in Fig. 2.
Theme 1: decision making
Societal bias toward life extension/Personal desire to
avoid death Patients spoke about the defibrillator in
absolute terms, as if there were no uncertainty regarding
the possible outcomes of ICD implantation. As one
patient said, “You either get the defibrillator and live, or
no defibrillator and die.” Another patient expressed a
sense of moral obligation to accept the ICD and try to
live as long as possible: “If somebody is told to have this
defibrillator and they don’t have it, shame on them.”
ICD as an “insurance policy” worth having Patients
frequently referred to their ICDs as a “safeguard” or an
“insurance policy.” For example, one patient stated, “I
don’t want to take any chances.” Another referred to it
as “a cautionary thing.”
Lack of participation in decision making/Reliance on
doctor to make the decision Many patients’ responses
suggest that they had played a passive role in the deci-
sion of whether or not to accept an ICD. For example,
one patient said, “I didn’t have no choice…It was either
get it put in, or just lay down and forget it…Go home
and lay down and die.” Another stated, “It was his
decision (the doctor’s) that I get it…He said it would be
in my interest.”
Consideration of competing health risks Only two
participants suggested that competing health risks might
play a role in their decision of whether or not to accept an
ICD. One patient, an 88-year-old woman, said, “At that
age, I didn’t know if they would determine you don’t need
it anymore…Not just because of your age, but that’s one
of the things they would consider.” Another patient
suggested that it would be preferable to die quickly of
sudden cardiac death, rather than face a progressive
illness: “I don’t know if I want them to put another one in
or not. If I’m gonna die, I’d rather die of a heart attack
than cancer…Let nature take its course.”
Theme 2: perceived benefits and burdens
Poor understanding of ICD risks and benefits/Belief
that ICD will improve quality of life A recurring
theme was that ICDs would improve quality of life. For
example, one patient said, “I guess without it, I probably
would be bedridden,” and another stated, “It keeps my
heart problems practically non-existent. It makes life a
little easier.” Most patients were unaware that one can
choose to accept a pacemaker for relief of symptoms, yet
forego the defibrillator to avoid shocks if life extension is
not a goal.
Burdens of living with an ICD Twelve patients dis-
cussed the burdens of living with an ICD. For example,
one man reflected, “I get disgusted thinking about carry-
ing this thing around and worrying about whether it’s
gonna go off.” Another said, “They never told me the
effect it would have on me when it went off… It was
from the soles of my feet to the top of my head.”
Patients generally expressed the belief that the potential
benefits of an ICD outweighed any burdens. However, as
described above, patients infrequently weighed these
tradeoffs in the decision of whether to accept an ICD.
ICD experiences and knowledge
Twenty-one respondents (47.7 %) had received a prior
ICD shock. Of the 23 respondents who had never been
Table 1 Demographics of survey respondents
N (%)
Age, mean (SD) 77.5 (5)
Sex, female 13 (29.6)
Race, white 39 (88.6)
Less than 12th grade education 16 (36.4)
Health literacy, mean (SD)a 2.3 (2.4)
Married 26 (59.1)
Comorbidities and geriatric syndromes, mean (SD) 6.9 (2.7)
VES-13 score, mean (SD) 3.0 (2.8)
VES-13 score ≥3 19 (43)
Years since ICD implantation, mean (SD) 7.3 (3.9)
Prior ICD shock 21 (47.7)
aWe assigned 0 (no problems with reading) to 4 points (highest problems with
reading) to the responses for each question. Scores for the 3 health literacy
screening questions were combined to obtain a 12-point scale, with 0 = no
problems with health literacy and 12 = highest problems with health
literacy [22].
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shocked, 7 thought the ICD had saved their life and 10
were unsure. Thirty-three participants (75 %) thought
there were no potential harms associated with their
ICDs (Fig. 3). Among shock recipients, 8 (38 %) were
able to name a harm associated with ICDs; these in-
cluded restrictions on driving and using welding equip-
ment, device malfunction, soreness, shocks, physical
appearance, and need for device replacement in the
future. Three (13 %) of the patients who had not been
shocked identified a harm associated with ICDs. One
participant reported an ICD-related complication (“It
shocked me because there was a malfunction”). When
asked about the survival benefit of ICDs, 43 % incor-
rectly assumed that an ICD confers a 50 % absolute
survival benefit over 5 years and 41 % said “don’t know”
(the survival benefit of ICDs in at-risk patients who have
not survived cardiac arrest is 5 to 7 % over 5 years).1, 2
When asked about the primary purpose of an ICD, fewer
Fig. 2 The figure depicts themes, subthemes and representative quotes that emerged as patients discussed their attitudes towards ICD
implantation in the context of competing health risks
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than half (43 %) answered correctly (“To prevent sudden
cardiac death”). Three participants thought an ICD
would improve symptoms of heart failure and 7 said
“don’t know.”
Discussion
The major finding of this study was that older adults
with multiple chronic conditions and ICDs remained
enthusiastic about device implantation despite high
short-term risk of death or functional decline. Nearly
half overestimated the survival benefit of ICDs. The
majority of patients did not consider their competing
health risks in their decision of whether or not to accept
an ICD, perhaps because they were unaware of their prog-
nosis, or because of a societal bias to embrace potentially
curative treatment, regardless of potential consequences.
Patients revealed considerable gaps in their under-
standing of ICDs. Importantly, 7 participants who had
never been shocked thought the ICD had saved their life
and 10 were unsure. Using a question from prior ICD
survey research [21], we found that nearly half of those
surveyed expected an ICD to save greater than 50 lives
per 100 during 5 years. The multiple choice question
presented absolute risks using frequencies, rather than
relative risks. This method has been shown to improve
patients’ understanding of risks and benefits, and is
considered “state of the science” in shared decision
making [25]. Poor grasp of complex medical information
is not isolated to defibrillator technology, nor does it
necessarily indicate that accurate information was not
conveyed to patients at the time of implantation. A
variety of factors may prevent older adults from achiev-
ing truly informed consent [26]. Marginal health literacy
may be one contributing factor; the results of the health
literacy screen suggest that patients in our sample per-
formed well with simple medical tasks but may sometimes
have had difficulty comprehending more complicated
medical information [22]. The patients in our study were
recalling discussions that happened years ago; we do not
know what they were told. Previous research has sug-
gested that cardiologists may downplay information about
psychological and long-term risks when discussing ICDs
with eligible patients [10, 27]. Our data do not allow us to
reach conclusions about the reason for patients’ poor
understanding of ICDs. In addition, we did not have infor-
mation on patients’ perceived health status. It is possible
that the participants considered themselves to be in rela-
tively good health with reasonable life expectancy, though
many had high VES-13 scores. This misunderstanding is a
barrier to informed consent and patient-centered care.
Our findings are consistent with previous studies, which
found that patients perceive an obligation to undergo
cardiac interventions despite advanced age, overestimate
the survival benefits conferred by ICDs, and are unwilling
to deactivate their devices even when presented with
hypothetical scenarios in which they are likely to die soon
of cancer or another noncardiac cause [21, 28]. Our data
expand upon previous qualitative studies of ICD decision-
making, which were small, included patients as young as
18 years [20, 29], or examined preferences for ICD deacti-
vation in the context of hypothetical health scenarios [20,
21]. One study found that the majority of patients (mean
age 71.4 years), after hearing an informational script about
the benefits and burdens of ICDs, would opt for ICD
deactivation in hypothetical end-of-life scenarios such as
advanced dementia or prolonged mechanical ventilation
[20]. Yet it has long been recognized that “the willingness
to suffer for a chance to postpone death may be felt more
acutely by those nearer to death,” [30] so it is not clear
how such patients would decide if in these clinical situa-
tions. Our study addressed a slightly different question,
ICD placement rather than deactivation. A major strength
of our study was that the patients were older and had a
higher prevalence of functional impairment than patients
in previous studies; 43 % of patients in our study had
VES-13 scores ≥3, conferring a 50 % likelihood of further
functional decline or death within 2 years.
Our findings are relevant given the large number of
older adults undergoing ICD implantation [2]. The deci-
sion to implant an ICD in older adults is complex,
particularly for primary prevention in patients who are
at risk for sudden cardiac arrest because of systolic
dysfunction but have never experienced a ventricular
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Fig. 3 The figure depicts the percentage of patients that gave each response to questions about ICD knowledge and beliefs
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receiving ICDs may not actually benefit from them, either
because they are not at high risk of sudden cardiac death
or because they are more likely to die of other causes; only
one-quarter of patients receive appropriate ICD shocks
within 5 years [31]. Many older patients have multiple
chronic conditions, increasing their risk of death from
non-arrhythmic causes. Current ICD guidelines recom-
mend against defibrillator implantation in patients with
life expectancy less than 1 year [6]. Functional status
measures such as those in the VES-13 are not routinely
obtained during cardiology office visits [18]. Functional
status falls outside the traditional disease model and is
often under-recognized by non-geriatricians, though it
predicts mortality and may impact the effectiveness of
ICD use, as well as an older adult’s decision to accept an
ICD. Older adults with multiple coexisting diseases and
functional impairments may weigh the potential benefits
and harms of ICD therapy differently if consent were truly
informed about the benefits and harms of ICDs and the
risk of competing health events [32, 33]. For those with
multiple chronic conditions and poor functional status,
the “rescue culture” of modern medicine can result in a
spiral of aggressive therapies that may have little potential
for benefit and may instead increase distress near the end
of life [13, 34, 35]. The societal imperative to avoid death
in frail, older patients may result in “new pathways to
death and new qualms for patients and families” [13, 28].
Our findings must be interpreted in the context of
several limitations, the first being survival bias. Study
participants had had their ICDs for an average of 7 years.
This suggests that these patients were appropriately
selected for ICD therapy, because they did not succumb
to competing health risks in the first few years after
implantation. Their responses may have been biased
because they had done well with their ICDs. However,
we asked patients if they would choose to get an ICD
again in their current health (irrespective of their baseline
health status). These patients were willing to undergo ICD
placement again, despite the fact that many had poor
functional status at the time of the study. This is import-
ant because many older adults with ICDs will survive long
enough to consider generator replacement, and their
health status may have declined since the initial implant.
A decision that may have been relatively straightforward
in the past may become more complex as an older adult’s
health status changes, and clinicians need to be attuned to
this when counseling patients and families about ICDs.
The second limitation is that only 44 of 104 eligible
subjects (excluding 4 who had died) completed the
survey. The 33 patients who were lost to clinic follow-up
and 12 who did not respond to repeated phone calls
were likely different than the patients who agreed to par-
ticipate. Patients who declined ICDs, no longer followed
up with the electrophysiology clinic, or died from ICD
complications or comorbidities likely have negative view-
points that we did not document. Only one participant
had experienced an ICD-related complication. Therefore,
the generalizability of our study to the broader population
of older adults with ICDs is uncertain. Despite these
caveats, our findings are important because they reveal a
high degree of misunderstanding about the potential
benefits and harms of ICDs.
The third limitation is that we were unable to distin-
guish between patients who received their ICDs for
primary or secondary indications. Patients’ attitudes may
differ depending on the indication for ICD therapy.
Fourth, our patients were recruited from a single aca-
demic cardiac device clinic. Their experiences may not
be representative of patients at other institutions.
Although we did not formally assess the rate of peripro-
cedural or late (≥90 days) complications among the
study population, we estimate that the rate at our insti-
tution is consistent with that reported in the literature
[7]. Patients at referral centers may be more likely to
accept treatment with invasive medical technologies [21].
Fifth, the investigator who made the initial contact with
potential participants is well-known to them because he
conducts all of their device interrogations, and this may
have positively influenced their perspectives toward ICD
therapy. Patients’ acceptance of ICDs is strongly influ-
enced by cardiologists’ opinions [29]. Sixth, our data did
not permit us to determine the timing of ICD shocks.
Patients may feel heightened anxiety and regret about
their ICD in the immediate post-shock period. Seventh,
the small sample size limits generalization.
A final limitation is that some of the patients had
pacemaker-defibrillators and may have conflated the two
separate functions of the device. For example, the patient
who said, “The only thing keeping me going is the defibril-
lator” may have had severe sinus node dysfunction that
improved after receiving a pacemaker-defibrillator. How-
ever, our consent script and questions explicitly stated that
the study was about defibrillators. Many patients have
indications for pacemakers and defibrillators, and they
should understand the distinction so that they can make
an informed choice. An ICD itself does not improve
quality of life. A patient with poor functional status and
limited life expectancy due to other comorbidities may
want a pacemaker but wish to forego the possibility of
defibrillator shocks.
Despite these limitations, this study expands previous
literature and raises important concerns about the quality
of ICD decision making for older adults with competing
health risks, and substantial patient misunderstanding
regarding the potential benefits and harms of ICD therapy.
Although the nation’s leading cardiology and heart failure
organizations have called for shared decision making
regarding cardiac implantable electronic devices and
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consideration of prognosis, physical function and quality
of life, cardiologists receive little if any formal training in
how to conduct such conversations with patients about
whether or not to pursue treatment with invasive tech-
nologies [36–38]. Furthermore, physician quality metrics
and professional society guidelines may serve as barriers
to patient-centered care by heavily influencing cardiolo-
gists’ decision making regarding ICDs [29, 39]. As a result,
clinicians may be reinforcing patient misperceptions, and
the care patients receive may frequently not be the care
they or their families would choose if properly informed
[21, 32, 40]. Decision aids are a potential solution to
improve ICD decision making [41]. A recent systematic
review identified 4 decision aids for patients considering
ICD insertion and found that the tools “included compre-
hensive content on technical aspects of insertion, but
made limited references to implications for quality of life
and generally lacked balance in terms of how the decision
to insert was presented.” [42] The development of high-
quality decision aids that address not only the technical
aspects of ICD insertion, but also issues related to how
ICDs may affect quality of life, is needed.
Incorporation of comprehensive geriatric assessment
has been recommended within the fields of geriatric
oncology and nephrology in order to identify risk factors
for increased vulnerability and inform treatment deci-
sions of older patients with cancer and end-stage renal
disease [43, 44]. Similarly, awareness of geriatric impair-
ment among older adults who are eligible for ICDs could
lead to improved clinical decision making.
Conclusions
Our primary finding was that most older adults with
ICDs do not weigh their competing health risks and life
expectancy in ICD decision making. This suggests the
need to develop innovative strategies for incorporating
non-disease specific assessment of prognosis in discus-
sions with ICD-eligible patients, and to partner more
effectively with patients and families to decide how best
to use medical technologies, particularly for older adults
with competing health risks.
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